Skip to main content
Clinical Trials/CTRI/2022/02/040014
CTRI/2022/02/040014
Completed
N/A

To evaluate the dermatological safety of investigational products by primary irritation patch test on healthy human volunteers of varied skin types

ITC LIMITED ITC Life Sciences and Technology Centre0 sites24 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
ITC LIMITED ITC Life Sciences and Technology Centre
Enrollment
24
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
February 16, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
ITC LIMITED ITC Life Sciences and Technology Centre

Eligibility Criteria

Inclusion Criteria

  • Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarââ?¬Â¦.)
  • Subjects representing varied skin types (ideally equal representation of all 4 skin types ââ?¬â?? Oily, Normal, Dry and combination) Subjects willing to come for regular follow up and ready to follow instructions during the study period

Exclusion Criteria

  • For female : Being pregnant or breastfeeding or having stopped to breastfeed in the past three months, Having refused to give his/her assent by signing the consent form, Taking part in another study liable to interfere with this study Being diabetic,Being asthmatic,Having eczema, oriasis, lichen plan, vitiligo whatever the considered area, Having disorder of the healing
  • (whatever the considered area),Having a rhinitis, allergic conjunctivitis or rhinosinusitis

Outcomes

Primary Outcomes

Not specified

Similar Trials